The Food Safety (Information and Compositional Requirements) (Amendment) Regulations (Northern Ireland) 2020

PART 1 Preliminary

Citation and commencement

1.  These Regulations may be cited as the Food Safety (Information and Compositional Requirements) (Amendment) Regulations (Northern Ireland) 2020 and come into operation on 22nd February 2020.

Interpretation

2.  In these Regulations—

“the 2016 Regulations” means the Food Safety (Information and Compositional Requirements) Regulations (Northern Ireland) 2016(1);

PART 2 Amendment of the 2016 Regulations

Amendment of the 2016 Regulations

3.  The 2016 Regulations are amended as follows.

Amendment of regulation 2 of the 2016 Regulations

4.—(1) In regulation 2 (Interpretation), for the definition of “the Delegated Regulation”, substitute—

““Delegated Regulation 127” means Commission Delegated Regulation (EU) 2016/127 of 25 September 2015 supplementing Regulation (EU) No 609/2013 of the European Parliament and of the Council as regards the specific compositional and information requirements for infant formula and follow-on formula and as regards requirements on information relating to infant and young child feeding(2);

Delegated Regulation 128” means Commission Delegated Regulation (EU) 2016/128 of 25 September 2015 supplementing Regulation (EU) No 609/2013 of the European Parliament and of the Council as regards the specific compositional and information requirements for food for special medical purposes(3);”

(2) For the definition of “specified EU requirement” substitute—

““specified EU requirement” means any provision of the EU Regulation or Delegated Regulation 127 or Delegated Regulation 128 specified in column 1 of Schedule 1, as read with the provisions specified in the corresponding entry in column 2.”.

(3) In regulation 2 (interpretation)—

(a) For paragraph (4) substitute—

“(4) Any reference to a provision of Delegated Regulation 127 or Delegated Regulation 128 contained in the table in Schedule 1 is a reference to that provision as amended from time to time.”.

(b) For paragraph (5) substitute—

“(5) Any expression used in both these Regulations and in Delegated Regulation 127 or Delegated Regulation 128 has the same meaning it bears in Delegated Regulation 127 or Delegated Regulation 128, as the case may be.”.

Amendment of regulation 8 of the 2016 Regulations

5.  For regulation 8 (Transitional Arrangements) substitute—

“8.— (1) Infant Formula and Follow on Formula that does not comply with any specified provision of Delegated Regulation 127 specified in Schedule 1 may continue to be marketed until stocks of such food are exhausted provided that—

(a) it complies with the provisions of the EU Regulation specified in Schedule 1;

(b) it was placed on the market or labelled—

(i) before 22nd February 2020; or

(ii) before 22nd February 2021 in the case of infant formula and follow-on formula manufactured from protein hydrolysates, and

(c) the requirements specified in the following provisions of the Infant Formula and Follow on Formula Regulations (Northern Ireland) 2007(4) are met —

(i) regulation 3(1) (prohibition on the marketing of infant formula unless certain conditions are met) in the case of infant formula; or

(ii) regulation 3(2) (prohibition on the marketing of follow-on formula unless certain conditions are met) in the case of follow on formula.

(2) Food for special medical purposes that does not comply with any specified provision of Delegated Regulation 128 specified in Schedule 1 may continue to be marketed until stocks of such food are exhausted provided that—

(a) it complies with the provisions of the EU Regulation specified in Schedule 1;

(b) it was placed on the market or labelled—

(i) before 22nd February 2019; or

(ii) before 22nd February 2020 in the case of food for special medical purposes developed to satisfy the nutritional requirements of infants, and

(c) the requirements specified in the following provisions of the Medical Food Regulations (Northern Ireland) 2000(5) are met-

(i) regulation 3(1) (restrictions on sale of a medical food);

(ii) regulation 3(2) (restrictions on sale of a medical food of a particular type).”.

Amendment of Schedule 1 to the 2016 Regulations

6.  In Schedule 1(6) to the 2016 Regulations (specified EU Requirements), substitute Schedule 1 of these Regulations.

PART 3 Revocations and savings

Revocations, savings and transitional provisions.

7.—(1) The Regulations specified in column 1 of the table in Schedule 2 are revoked to the extent specified in column 3, subject to paragraph (2).

(2) The Regulations specified in column 1 of the table in Schedule 2 continue to have effect (so far as otherwise revoked to the extent specified in column 3 of that table)—

(a) until 21st February 2021 in respect of infant formula and follow-on formula manufactured from protein hydrolysates;

(b) for the purposes of regulation 8(1)(c) and regulation 8(2)(c) of the 2016 Regulations as substituted by regulation 5 of these Regulations.

Sealed with the official seal of the Department of Health on 27th January 2020.

Dr Naresh Chada

A senior officer of the Department of Health